MYE0.F MAXCYTE INC DL-01

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.9900 EUR
Close of Nov 12, 2026
0.5550 1.51
Market cap
EUR 102M
P/E
-
P/B
0.76x
ROE
-16.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MYE0.F undervalued?

Graham number

The Graham number of MAXCYTE INC DL-01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MAXCYTE INC DL-01 fundamental analysis

No fundamental analysis for MAXCYTE INC DL-01 yet.

MAXCYTE INC DL-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MAXCYTE INC DL-01

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in t…

Full company profile